Swedish Orphan Biovitrum (Sobi) has agreed a $1.7 billion merger deal to acquire CTI BioPharma and its recently-approved Vonjo drug for people with blood cancer myelofibrosis and severe ...

CTI is a high volume manufacturer of oxide single crystals and Acousto-Optical components worldwide, we have leadership in quality, low-cost and R&D. We produce 60 tons/yr of Li Niobate, and have ...

Coloured Ties Capital Inc. (TSXV: TIE) (OTC Pink: APEOF) (FSE: 97A0) ("CTI" or the "Company") announces that on March 4, 2025 ...

Coloured Ties Capital Inc. (TSXV: TIE) (OTC Pink: APEOF) (FSE: 97A0) ("CTI" or the "Company") announces today that Zara Kanji is no longer Chief Financial Officer for the Company and Harry Nijjar has ...

Ariel Glassner, MIND CTI’s Chief Executive Officer, commented: “The impact of global economic conditions, industry consolidation, emergence of new competitors and commoditization of telecom ...